BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 16014527)

  • 1. Long-lived plasma cells and their contribution to autoimmunity.
    Hoyer BF; Manz RA; Radbruch A; Hiepe F
    Ann N Y Acad Sci; 2005 Jun; 1050():124-33. PubMed ID: 16014527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice.
    Hoyer BF; Moser K; Hauser AE; Peddinghaus A; Voigt C; Eilat D; Radbruch A; Hiepe F; Manz RA
    J Exp Med; 2004 Jun; 199(11):1577-84. PubMed ID: 15173206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
    Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
    Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
    Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
    Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F
    J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to cope with pathogenic long-lived plasma cells in autoimmune diseases.
    Hoyer BF; Mumtaz IM; Yoshida T; Hiepe F; Radbruch A
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii87-9. PubMed ID: 19022822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-1 cells and autoimmunity.
    Murakami M; Honjo T
    Ann N Y Acad Sci; 1995 Sep; 764():402-9. PubMed ID: 7486555
    [No Abstract]   [Full Text] [Related]  

  • 9. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
    Neubert K; Meister S; Moser K; Weisel F; Maseda D; Amann K; Wiethe C; Winkler TH; Kalden JR; Manz RA; Voll RE
    Nat Med; 2008 Jul; 14(7):748-55. PubMed ID: 18542049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of long-lived plasma cells in autoimmunity.
    Arce S; Cassese G; Hauser A; Dörner T; Odendahl M; Manz R; Radbruch A; Hiepe F
    Immunobiology; 2002 Dec; 206(5):558-62. PubMed ID: 12607731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological pathogenesis of collagenosis].
    Lorente Toledano F; Blanco Quirós A; Muriel Ramos MM
    An Esp Pediatr; 1981 Jul; 15(1):23-30. PubMed ID: 6976141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinations of B cell fate in immunity and autoimmunity.
    Noelle RJ; Erickson LD
    Curr Dir Autoimmun; 2005; 8():1-24. PubMed ID: 15564715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lived plasma cells in immunity and immunopathology.
    Moser K; Muehlinghaus G; Manz R; Mei H; Voigt C; Yoshida T; Dörner T; Hiepe F; Radbruch A
    Immunol Lett; 2006 Mar; 103(2):83-5. PubMed ID: 16280169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoantibodies and antibody-secreting cells].
    Hiepe F; Dörner T
    Z Rheumatol; 2005 Sep; 64(6):389-95. PubMed ID: 16184346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity and lymphoid malignancy in New Zealand black mice.
    Talal N
    Prog Clin Immunol; 1974; 2():101-20. PubMed ID: 4141778
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma cells as an innovative target in autoimmune disease with renal manifestations.
    Hiepe F; Radbruch A
    Nat Rev Nephrol; 2016 Apr; 12(4):232-40. PubMed ID: 26923204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity.
    Neves M; Alves JD
    Autoimmun Rev; 2011 May; 10(7):375-82. PubMed ID: 21224017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.
    Xiang Z; Cutler AJ; Brownlie RJ; Fairfax K; Lawlor KE; Severinson E; Walker EU; Manz RA; Tarlinton DM; Smith KG
    Nat Immunol; 2007 Apr; 8(4):419-29. PubMed ID: 17322888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell lines.
    Kurth J; Perniok A; Schmitz R; Iking-Konert C; Chiorazzi N; Thompson KM; Winkler T; Rajewsky K; Küppers R
    Eur J Immunol; 2002 Dec; 32(12):3785-92. PubMed ID: 12516573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.